期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

适配体及其在动物医学领域中的应用研究进展 被引量：1

Advance in aptamers and its application to veterinary medicine
原文传递
导出
摘要 简要介绍了适配体的概念及其优点,从治疗药物的选择、小分子物质检测及基因调控等领域对适配体的研究现状进行了综述,叙述了适配体在动物疾病治疗、动物性食品中抗生素残留的检测以及动物性食品中微生物污染的检验等动物医学领域的应用情况。 The concept of aptamer and its advantages were summarized,the research status of aptamers was reviewed on the aspects of drug selection of therapy,detection of small molecules and gene regulation,and its applications to the treatment of animal diseases and the detections of antibiotics remains and microorganism in the foods from animals were summarized.
作者 王开 裴志花 高云航 马红霞
机构地区 吉林农业大学动物科学技术学院
出处 《中国兽医科学》 CAS CSCD 北大核心 2010年第7期762-765,共4页 Chinese Veterinary Science
基金 吉林农业大学青年启动基金项目(2009020)
关键词 适配体 应用 动物医学 aptamers application veterinary medicine
分类号 R978.7 [医药卫生—药品] R914 [医药卫生—药物化学]
  • 相关文献

参考文献32

  • 1THOMAS H,PATEL J D.Adaptive recognition by nucleic acid aptamers[J].Science,2000,287(5454):820-825.
  • 2PATEL D J,SURI A K.Structure,recognition and discrimination in RNA aptamer complexes with cofactors,amino acids,drugs and aminoglycoside antibiotics[J].J Biotechnol,2000,74(1):39-60.
  • 3MISSAILIDIS S,THOMAIDOU D,BORBAS K E,et al.Selection of aptamers with high affinity and high specificity against C595,an anti-MUC1 IgG3 monoclonal antibody,for antibody targeting[J].J Immunol Methods,2005,296(112):45-62.
  • 4COX J C,ELLINGTON A D.Automated selection of anti-protein aptamers[J].Bioorg Med Chem,2001,9(10):2525-2531.
  • 5COX J C,HAYHURST A,HESSELBERTH J,et al.Automated selection of aptamers against protein targets translated in vitro:from gene to aptamer[J].Nucleic Acids Res,2002,30(20):104-108.
  • 6JAYASENA S D.Aptamers:an emerging class of molecules that rival antibodies in diagnostics[J].Clin Chem,1999,45(9):1628-1650.
  • 7Eyetech Study Group.Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration:phase Ⅱ study results[J].Ophthalmology,2003,110(5):979-986.
  • 8BLANK M,BLIND M.Aptamers as tools for target validation[J].Curr Opin Chem Biol,2005,4(9):336-342.
  • 9SACCUCCI L,CRANCE J M,COLAS P.Inhibition of vaccinia virus replication by peptide aptamers[J].Antiviral Res,2009,82(3):134-140.
  • 10TRAHTENHERTS A,GAL-TANAMY M,ZEMEL R,et al.Inhibition of hepatitis C virus RNA replicons by peptide aptamers[J].Antiviral Res,2008,77(3):195-205.

二级参考文献45

  • 1张莹,魏文宁.凝血酶活性的检测及临床意义[J].微循环学杂志,2005,15(2):70-72. 被引量：8
  • 2Gill D M. Bacterial toxins: a table of lethal amounts[J]. Microbiol Rev, 1982,46( 1 ) :86-94.
  • 3Fueyo J M,Martin M A,Mendoza M C,et al. Enterotoxin production and DNA fingerprinting in Staphylococcus aureus isolated from human and food samples. Relations between genetic types and enterotoxins [J]. Int J Food Microbiol,2001,67 (1-2) : 139-145.
  • 4Papageorgiou A C, Tranter H S, Acharya K R,et al. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class Ⅱ molecules and T-cell receptors[ J ]. Mol Bial, 1998,277 (1) :61-79.
  • 5Faulkner L, Cooper A, Fantino C, et al. The mechanism of superantigen-mediated toxic shock: not a simple Thl cytokinestorrn [ J ]. Immunol,2005,15(10) : 6870-6877.
  • 6Mallikaratchy P,Tang Z, Kwame S,et al. Aptamer directly evolved from live ceils recognizes membrane bound immunoglobin heavy mu chain in Brukitt's lymphomacells [ J ]. Mol Cell Proteomics, 2007,6 (12) : 2230-2238.
  • 7Blaiotta G V, Fusco C, Becker K, et al. Biotyping of enterotoxigenie Staphylococcus aureus by enterotoxin gene cluster (egc) polymorphism and spa typing analyses [ J ]. Appl Environ Microbiol, 2006,72 ( 9 ): 6117-6123.
  • 8Morris C,Tam C K, Wallis T S,et al. Salmonella enterica servoar Dublin strains which are Vi antigen positive use type IVB pili for bacterial self-association and human intestinal cell entry. Microb Pathog, 2003,35:279-284.
  • 9Lyczak J B, Pier G B. Salmonella enterica serovar Typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the epithelium. Infect Immun, 2002, 70: 6416-6423.
  • 10Zhang X L, Tsui I S, Yip C M, et al. Salmonella enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells. Infect Immun, 2000,68: 3067-3073.

共引文献25

同被引文献35

  • 1潘勤,章晓联,汪付兵,何攀文,吴红艳,屈雪菊,戚中田.运用SELEX技术筛选特异性高亲和IVB型纤毛结构蛋白RNA适配子[J].中国生物制品学杂志,2004,17(5):280-283. 被引量：4
  • 2尤晓光,白玉杰,涂蓉.MR靶向对比剂前体——VEGF165-适配体与VEGF165体外结合实验研究[J].国际医学放射学杂志,2011,34(1):9-11. 被引量：3
  • 3汤庆超,王锡山.纳米药物应用于肿瘤治疗的研究进展[J].实用肿瘤学杂志,2006,20(5):441-443. 被引量：5
  • 4Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase [J]. Science, 1990, 249(4968): 505-510.
  • 5Barakat M R, Kaiser P K.VEGF inhibitors for the treatment of neovascular age-related macular degeneration [J]. Expert Opin Investig Drugs, 2009, 18(5): 637-646.
  • 6Kaur G, Roy I. Therapeutic applications of aptamers [J]. Expert Opin Investig Drugs, 2008, 17(1): 43-60.
  • 7Blank M, Blind M. Aptamers as tools for target validation [J]. Curr Opin Chem Biol, 2005, 4(9): 336-342.
  • 8Muller J, Wulefen B, Potzsch B, et al. Multidomain targeting generates a high-affinity thombin-inhibiting bivalent aptamer [J]. Chem Biochem, 2007, 8(18): 2223-2226.
  • 9Rusconi C P, Roberts J D, Pttoc G A, et al. Antidote-mediated control of an anticoagulant aptamer in vivo [J]. Nat Biotechnol J, 2004, 22(11): 1373-1384.
  • 10Pendergrast P S, Marsh H N, Grate D, et al. Nucleic acid aptamers for target validation and therapeutic applications [J]. J Biomol Tech, 2005, 16(3): 224-234.

引证文献1

二级引证文献1

中国兽医科学
2010年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部